NCT02707887

Brief Summary

The purpose of this study is to:

  1. 1.test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use
  2. 2.use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2015

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 14, 2016

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

October 16, 2023

Status Verified

January 1, 2021

Enrollment Period

4.9 years

First QC Date

May 27, 2015

Last Update Submit

October 13, 2023

Conditions

Keywords

Mental DisordersMood DisordersBehavioral Activation

Outcome Measures

Primary Outcomes (1)

  • Timeline Followback (TLFB)

    The Time Line Follow Back is a self-report measure of drug and alcohol use.

    TLFB will be assessed from baseline to a 12-month follow up period.

Secondary Outcomes (8)

  • Behavioral Activation for Depression Scale (BADS)

    BADS will be assessed from baseline to a 12-month follow up period.

  • Reward Probability Index (RPI)

    RPI will be assessed from baseline to a 12-month follow up period.

  • Beck Depression Inventory-II (BDI-II)

    BDI-II will be evaluated from baseline to a 12-month follow up period

  • Daily Goals Form

    Baseline to a 3-months post treatment.

  • Texas Christian University (TCU) HIV/AIDS Risk Assessment Form

    TCU will be assessed from baseline to a 12-month follow up period.

  • +3 more secondary outcomes

Study Arms (3)

Treatment as Usual

PLACEBO COMPARATOR

Patients are offered substance use group therapy including relapse prevention. They are also provided medical consultation on an ongoing basis as needed.

Behavioral: Treatment as Usual

LETS ACT

ACTIVE COMPARATOR

The Life Enhancement Treatment for Substance Use (LETS ACT) involves the discussion of the treatment rationale, identification of values and goals in various life areas and activities in line with chosen life areas, and training for patients to identify their cycle of negative mood and behavior using forms to track their daily goals.

Behavioral: LETS ACTBehavioral: Treatment as Usual

LETS ACT-SE

ACTIVE COMPARATOR

Participants assigned to the smartphone-enhanced LETS ACT (LETS ACT-SE) condition will be provided the exact same treatment as outlined in LETS ACT, except that LETS ACT-SE participants will record their daily goals using smartphone technology.

Behavioral: LETS ACT-SEBehavioral: Treatment as Usual

Interventions

LETS ACTBEHAVIORAL

The Life Enhancement Treatment for Substance Use (LETS ACT)

Also known as: Behavioral Activation, Life Enhancement Treatment for Substance Use
LETS ACT
LETS ACT-SEBEHAVIORAL

Participants assigned to the smartphone-enhanced LETS ACT (LETS ACT-SE) condition will be provided the exact same treatment as outlined in LETS ACT, except that LETS ACT-SE participants will record their daily goals using smartphone technology.

Also known as: Behavioral Activation, Smartphone-Enhanced LETS ACT
LETS ACT-SE

Participants will receive the treatment typically provided to patients at the substance use treatment facility.

Also known as: TAU
LETS ACTLETS ACT-SETreatment as Usual

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18 and 55
  • Meet criteria for DSM-V substance use disorder
  • Elevated depressive symptoms (BDI ≥ 14)

You may not qualify if:

  • Limited mental competency (MMSE \< 23)
  • Psychosis
  • The use of psychotropic medication for \< 3 months
  • The inability to give informed, voluntary, written consent to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-3270, United States

Location

Southlight Healthcare

Raleigh, North Carolina, 27604, United States

Location

Related Publications (2)

  • Kane L, Reese ED, Paquette C, Paladino M, Linares Abrego P, Daughters SB. Substance use negatively impacts change in reinforcement during the year following substance use treatment. Psychol Addict Behav. 2025 May;39(3):238-253. doi: 10.1037/adb0001051. Epub 2025 Jan 9.

  • Paquette CE, Rubalcava DT, Chen Y, Anand D, Daughters SB. A Mobile App to Enhance Behavioral Activation Treatment for Substance Use Disorder: App Design, Use, and Integration Into Treatment in the Context of a Randomized Controlled Trial. JMIR Form Res. 2021 Nov 3;5(11):e25749. doi: 10.2196/25749.

MeSH Terms

Conditions

Substance-Related DisordersDepressive DisorderBehavioral SymptomsRisk-TakingSexual BehaviorMental DisordersMood Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersBehavior

Study Officials

  • Stacey Daughters, Ph.D.

    University of North Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2015

First Posted

March 14, 2016

Study Start

January 1, 2016

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

October 16, 2023

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations